Compare IRWD & AMBQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | AMBQ |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 533.3M |
| IPO Year | 2010 | 2025 |
| Metric | IRWD | AMBQ |
|---|---|---|
| Price | $3.32 | $29.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $5.34 | ★ $41.75 |
| AVG Volume (30 Days) | ★ 2.3M | 89.8K |
| Earning Date | 11-10-2025 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $338,987,000.00 | $72,109,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.01 | $22.30 |
| P/E Ratio | $19.03 | ★ N/A |
| Revenue Growth | N/A | ★ 10.03 |
| 52 Week Low | $0.53 | $22.12 |
| 52 Week High | $4.78 | $51.76 |
| Indicator | IRWD | AMBQ |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | N/A |
| Support Level | $3.11 | N/A |
| Resistance Level | $3.39 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 36.36 | 0.00 |
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.